62 filings
8-K
ZNTL
Zentalis Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
7:00am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
29 May 24
Departure of Directors or Certain Officers
7:04am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
7 May 24
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
7:03am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
11 Apr 24
Departure of Directors or Certain Officers
7:00am
8-K
ZNTL
Zentalis Pharmaceuticals Inc
9 Apr 24
Regulation FD Disclosure
4:30pm
8-K
kxi1c82
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
8-K
l8kgwhpgu
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
uil5uhy4 rof4
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
x8hmg2r pcl4yckfl
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
ueto5i99 jq
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
l5h7sbb
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
rpkus2wj0hdkh igt5
13 Sep 23
Regulation FD Disclosure
7:00am
8-K
omjr2n
9 Aug 23
Regulation FD Disclosure
4:15pm
8-K
ffobi7s6
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
8-K
95s8arg6chxktw8z nx
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
5:19pm
8-K
1eofr7
15 Jun 23
Other Events
4:23pm
8-K
erb0f56pf
15 Jun 23
Other Events
6:02am
8-K
v9ipmyny1mu3fcke
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
9t35gl 6ji
5 Jun 23
Regulation FD Disclosure
2:24pm
8-K
x7zvqh5x7snx0kh496
26 May 23
Regulation FD Disclosure
12:38pm